The SHARE study is an international multidisciplinary longitudinal survey. The panel survey has been conducted approximately every other year for over 20 years. In an analysis published in 2025, data from the ninth wave of the survey was analyzed to find out more about the prevalence of polypharmacy in different countries and to break down which factors are associated with it.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Neuroendocrine tumors
Precision medicine in diagnostics and therapy
- Irritable Bowel Syndrome
Functional disorder of gut-brain interaction – a biopsychosocial concept
- GLP1 receptor agonists
Positive influence on substance use and addiction
- Sleep apnea and cardiovascular diseases
Breathless through the night
- Diagnostics, differentiation and multimodal therapy
Vulvar diseases and vulvodynia
- From symptom to diagnosis
Abdominal pain – Prostate lipoma
- Acute pulmonary embolism: new AHA/ACC guideline
Practical recommendations for risk-stratified triage
- Why lipoprotein(a) is the biggest therapeutic vacuum in cardiology